DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20202741

Clinical study of gestational trophoblastic disease in a tertiary care hospital

Jayashree Mulik, Archana Choudhary

Abstract


Background: Gestational trophoblastic diseases (GTDs) had been associated with significant morbidity and mortality till recently. Wide variation in incidences have been reported worldwide. The present study was planned with the objective of determination of incidence, assessment of risk factors, clinical presentation, management protocols and outcomes in GTD cases in Indian population at a tertiary care centre.

Methods: All the diagnosed cases of GTD reporting to study centre during study period of 1.5 years were included. Detailed history taking, examination and relevant investigations (Hb%, blood grouping, thyroid functions, serum ß-hCG, USG and chest X-ray) were undertaken. Suction and evacuation were done for all patients as primary mode of management and samples were sent for histopathological examination. Comprehensive follow ups were done, including weekly ß-hCG until normal for 3 consecutive weeks followed by monthly determination until the levels were normal for 6 consecutive months.

Results: Total 22 cases out of 19500 deliveries were diagnosed as GTD (incidence rate-1.13/1000 deliveries). Mean age was 23.64±3.89 years with 50% participants being primigravida. The commonest symptom after amenorrhea 22 (100%) was bleeding per-vaginum 15 (68.2%). Maximum cases were of complete hydatidiform mole histopathology 16 (72.73%), USG 19 (86.4%). Clinical characteristics were statistically comparable between patients of complete mole and partial mole. Out of 22 cases, 1 (4.5%) was diagnosed as GTN.

Conclusions: Early diagnosis and treatment along with regular follow up is the key in GTD. There is need to establish a centralized disease specific registry in future.


Keywords


Gestational trophoblastic diseases, Gestational trophoblastic neoplasia, Hydatidiform mole, ß-hCG

Full Text:

PDF

References


Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. The Lancet. 2010;376(9742):717-29.

Matsui H, Iitsuka Y, Yamazawa K, Tanaka N, Seki K, Sekiya S. Changes in the incidence of molar pregnancies. A population‐based study in Chiba Prefecture and Japan between 1974 and 2000. Human Reprod. 2003;18(1):172-5.

Steigrad SJ. Epidemiology of gestational trophoblastic diseases. Best practice and research. Clin Obstet Gynaecol. 2003;17(6):837-47.

Smith HO, Qualls CR, Prairie BA, Padilla LA, Rayburn WF, Key CR. Trends in gestational choriocarcinoma: a 27-year perspective. Obstet Gynecol. 2003;102(5):978-87.

Rangwala TH, Badawi F. A profile of cases of gestational trophoblastic neoplasia at a large tertiary centre in Dubai. Obstet Gynecol. 2011;2011.

Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001;11(1):73-7.

Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994;39(3):155-62.

Ngan HY, Odicino F, Maisonneuve P, Creasman WT, Beller U, Quinn MA, et al. Gestational trophoblastic neoplasia. Int J Gynecol Obstet. 2006;95:S193-203.

Nirmala CK, Nor Azlin MI, Harry SR, Lim PS, Shafiee MN, Nur Azurah AG, et al. Outcome of molar pregnancies in Malaysia: a tertiary centre experience. J Obstet Gynaecol. 2013;33(2):191-3.

Kumar N, Saxena YK, Rathi AK, Chitra R, Kumar P. Host and risk factors for gestational trophoblastic disease: a hospital-based analysis from India. Med Sci Monitor. 2003;9(10):442-7.

Tham BW, Everard JE, Tidy JA, Drew D, Hancock BW. Gestational trophoblastic disease in the Asian population of Northern England and North Wales. Int J Obstet Gynaecol. 2003;110(6):555-9.

Brinton LA, Bracken MB, Connelly RR. Choriocarcinoma incidence in the United States. Am J Epidemiol. 1986;123(6):1094-100.

Ocheke AN, Musa J, Uamai AO. Hydatidiform mole in Jos, Nigeria. J Nigeria Med Association. 2011;52(4):223.

Fatima M, Kasi PM, Baloch SN, Kassi M, Marri SM, Kassi M. Incidence, management, and outcome of molar pregnancies at a tertiary care hospital in Quetta, Pakistan. ISRN Obstet Gynecol. 2011;2011:925316.

Koirala A, Khatiwada P, Giri A, Kandel P, Regmi M, Upreti D. The demographics of molar pregnancies in BPKIHS. Kathmandu Univer Med J. 2011;9(4):298-300.

Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol. 2003;101(4):732-6.

Massad LS, Abu-Rustum NR, Lee SS, Renta V. Poor compliance with postmolar surveillance and treatment protocols by indigent women. Obstet Gynecol. 2000;96(6):940-4.

Lybol C, Thomas CM, Bulten J, van Dijck JA, Sweep FC, Massuger LF. Increase in the incidence of gestational trophoblastic disease in The Netherlands. Gynecol Oncol. 2011;121(2):334-8.